REPROGRAMMING THE TUMOR MICROENVIRONMENT TO IMPROVE HEARING AND TREATMENT EFFICACY IN NF2 VESTIBULAR SCHWANNOMA.

$742,819FY2020Defense Health AgencyDOD

The General Hospital Corporation

Investigators